Cidara Therapeutics, Inc.

New Filing
CIK: 0001610618·Biotechnology·DELAWARE·Filed: Oct 31, 2017
Total Offering

$20,160,000

Amount Sold

$20,160,000

Investors

16

First Sale

Oct 24, 2017

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2012
Non-Accredited Investors
No

Related Persons

NameRole
Jeffrey Stein
Related Person
Kevin Forrest
Related Person
Daniel D. Burgess
Related Person
Scott M Rocklage
Related Person
Theodore R. Schroeder
Related Person
Robert J Perez
Related Person
Timothy R Franson
Related Person
Matthew Onaitis
Related Person
Taylor Sandison
Related Person
Ken Bartizal
Related Person
Paul Daruwala
Related Person
Neil Abdollahian
Related Person

Company

Cidara Therapeutics, Inc.

6310 NANCY RIDGE DRIVE

SAN DIEGO, CA, 92121

858-752-6170

SEC Filing

0001610618-17-000053

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free